13 June 2019, 09:30 – 15:30
Location: Atrium, Royal Free Hospital
Encouraging patient participation in research, the treatment of sclerosis, transformation of outcomes in melanoma and the latest from the 100,000 genomes project, are just some of the talks being given at the Royal Free London (RFL) annual research and development open day on Thursday, 13 June.
There will also be interactive stands from a number of teams including therapies, clinical microbiology and the pharmacy manufacturing unit. In addition there will be a conference style poster competition from researchers and students. A number of schools will be attending the event, which is open to everyone and will run from 9.30am to 3.30pm.
The RFL recruits more than 12,000 patients annually to research projects and has more than 700 studies helping to improve the lives of our patients.
Farhan Naim, director of research and development at the RFL, will be introducing the day. There will also be an interesting ‘in conversation’ session on the future of drug discover and the role machine learning might play in the afternoon.
Farhan said: “This is a brilliant event which we hope will spark interest from patients, staff and visitors. Research and development is embedded in our trust’s DNA and we are really excited to be able to share our progress and what this means for patients.
“The Royal Free London believes clinical research is key to delivering excellent patient care. We are proud to be a research active trust and value our excellent investigators, outstanding research workforce and research patients.”
10-10.05am: Introduction by Farhan Naim, director of research and development
10.05-10.45am: Making research more open - a place for patients and the public to play a part. Derek Stewart OBE, advocate for patient involvement in research
10.45-11.25am: Stem cell enriched lipotransfer in the treatment of systemic sclerosis by Professor Peter Butler
11.40am-12pm: Cancer immunotherapy- the transformation of outcomes in melanoma by Dr David Chao
12-12.20pm: Surgeon led research at the specialist centre for kidney cancer, the largest kidney cancer center in the UK by Miss Maxine Tran
12.50-1.10pm: The 100,000 genomes project by Dr Daniel Gale
1.10-1.30pm: Gene therapy for haemophilia by Professor Amit Nathwani
1.30-1.50pm: Sleep disorder research by Dr Swapna Mandall and Ms Stephanie Mansell
2.05-2.25pm: Hepatology research by Professor William Rosenberg
1.10-1.30pm: In conversation: The future for drug discovery and the role machine learning might play
3.15-3.30pm: Closing remarks and announcement of competition winners